Soybeans continue to set and fill pods: Bean Report

Aug 17, 2022

Manitoba Pulse and Soybean Growers (MPSG) says soybeans are continuing to set and fill pods.

MPSG Production Specialist Jennifer McCombe-Theroux gave us an update.

"Most fields ranging from the R4 stage, where pods are three quarters of an inch long at one of the top four nodes, to R5, the beginning seed stage. We are seeing and hearing of soybean aphids across the province, with some at spraying thresholds. Grasshoppers are also continuing to be a challenge in some fields and will need to continue to be monitored."

She also commented on field peas.

"They're ranging from the R4, the full pod stages, to R6, a mid-maturity staging. With some earlier planted fields getting closer to harvest at the R7 staging. This is where 75 to 80 per cent of the pods are golden brown in colour. We are seeing some yellowing of field peas due to saturated soils, resulting in root rots. It's a good idea to get these plants tested to understand which root rot it is."

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.